Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

NCT02691923 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer

Interventions

DRUG: Fluorescein
DRUG: Fluorescein + ALA

Sponsor

David W. Roberts

Collaborators

[object Object]
[object Object]